Latest Breaking News On - Rxsight daily - Page 14 : comparemela.com

RxSight, Inc (NASDAQ:RXST) Director Sells $120,433 52 in Stock

RxSight, Inc. (NASDAQ:RXST – Get Free Report) Director Shweta Maniar sold 4,292 shares of the company’s stock in a transaction on Tuesday, August 29th. The shares were sold at an average price of $28.06, for a total transaction of $120,433.52. Following the completion of the sale, the director now directly owns 24,947 shares of the […]

United statesShweta maniarWells fargo companyRxsight incAmeritas investment partners incNeedham companyLazard asset managementAdvisors incCubist systematic strategiesGet free reportDirector shweta maniarSight stock downInvestment partnersSystematic strategiesRxsight dailyNasdaq rxst

RxSight, Inc (NASDAQ:RXST) Director Sells $474,084 00 in Stock

RxSight, Inc (NASDAQ:RXST) Director Sells $474,084 00 in Stock
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesBakker juliet tammenomsNeedham companyRxsight incVanguard group incCentury growth investorsArtisan partners limited partnershipRxsight company profileWells fargo companyBlackrock incGet free reportDirector bakker juliet tammenomsJuliet tammenomsSight stock downPartners limited partnershipRxsight daily

Shweta Maniar Sells 4,292 Shares of RxSight, Inc (NASDAQ:RXST) Stock

Shweta Maniar Sells 4,292 Shares of RxSight, Inc (NASDAQ:RXST) Stock
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesShweta maniarAmeritas investment partners incCounterpoint mutual fundsRxsight incLazard asset managementNeedham companyInvestment advisersAdvisors incSecurities exchange commissionWells fargo companyGet free reportDirector shweta maniarExchange commissionWells fargoInvestment partners

Oppenheimer Raises RxSight (NASDAQ:RXST) Price Target to $34 00

RxSight (NASDAQ:RXST – Free Report) had its price target raised by Oppenheimer from $29.00 to $34.00 in a research note issued to investors on Tuesday, Marketbeat Ratings reports. The firm currently has an outperform rating on the stock. A number of other research firms have also recently commented on RXST. Needham & Company LLC reiterated […]

United statesNeedham companyBlackrock incRxsight company profileYork mellon corpRxsight incVanguard group incJpmorgan chase coWells fargo companyFree reportMarketbeat ratingsModerate buyGet free reportNew york mellon corpVanguard groupRxsight daily

RxSight, Inc (NASDAQ:RXST) Short Interest Up 27 1% in July

RxSight, Inc. (NASDAQ:RXST – Get Free Report) was the recipient of a large increase in short interest during the month of July. As of July 15th, there was short interest totalling 1,360,000 shares, an increase of 27.1% from the June 30th total of 1,070,000 shares. Currently, 5.8% of the shares of the company are sold […]

United statesRussell investments group ltdRxsight incNeedham companyWells fargo companyTranscend capital advisorsCounterpoint mutual fundsGet free reportInvestments groupCapital advisorsRxsight daily